What's in Alrijne Ziekenhuis Leiderdorp's pipeline?

Alrijne Ziekenhuis Leiderdorp has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Alrijne Ziekenhuis Leiderdorp's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Australian and New Zealand Intensive Care Research Centre, Rutgers, The State University of New Jersey.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alrijne-ziekenhuis-leiderdorp.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Alrijne Ziekenhuis Leiderdorp — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alrijne Ziekenhuis Leiderdorp pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Deep-frozen platelets	Deep-frozen platelets	phase 3	Blood product / Cellular therapy		Hematology / Transfusion Medicine

Therapeutic area mix

Hematology / Transfusion Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Australian and New Zealand Intensive Care Research Centre · 1 shared drug class
Rutgers, The State University of New Jersey · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Alrijne Ziekenhuis Leiderdorp:

Cite this brief

Drug Landscape (2026). Alrijne Ziekenhuis Leiderdorp — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alrijne-ziekenhuis-leiderdorp. Accessed 2026-05-17.